StimTrial Neuromodulation System

FDA 510(k) K243782 · Bioventus, LLC

Substantially Equivalent

510(k) numberK243782

Submission

Device name
StimTrial Neuromodulation System
Applicant
Bioventus, LLC
Durham, NC, US
Received
December 9, 2024
Decision date
July 16, 2025
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
GZF – Stimulator, Peripheral Nerve, Implanted (Pain Relief)
Device class
Class II (moderate risk)
Regulation
21 CFR 882.5870
Specialty
Neurology
Implant
Yes

Other 510(k)s with product code GZF

510(k)DeviceApplicantDecision
K253877StimTrial Neuromodulation SystemGZF · Special Bioventus, LLC08/26/2026SE
K243678TalisMann Neuromodulation SystemGZF · Traditional Bioventus, LLC07/03/2025SE
K232415Nalu Neurostimulation System for Peripheral Nerve StimulationGZF · Traditional Boston Scientific Neuromodulation08/21/2024SE
K233162Freedom Peripheral Nerve Stimulator (PNS) SystemGZF · Traditional Curonix06/20/2024SE
K221303Neuspera Nuity SystemGZF · Traditional Neuspera Medical, Inc.04/11/2023SE
K211965StimRouter Neuromodulation SystemGZF · Traditional Bioness, Inc.02/23/2022SE
K202781Neuspera Neurostimulation System (NNS)GZF · Traditional Neuspera Medical, Inc.08/27/2021SE
K200848Stimulator, Stimulator Kit, External Transmitter, External Transmitter KitGZF · Traditional Micron Medical Corporation08/14/2020SE
K200482StimRouter Neuromodulation SystemGZF · Special Bioness, Inc.03/27/2020SE
K190047StimRouter Neuromodulation SystemGZF · Traditional Bioness, Inc.10/31/2019SE

More from Bioness, Inc.

510(k)DeviceDecision
K253877StimTrial Neuromodulation SystemGZF · Special 08/26/2026SE
K243678TalisMann Neuromodulation SystemGZF · Traditional 07/03/2025SE
K233368Allograft Delivery Device (OFAC-C)FMF · Traditional 06/25/2024SE
K233490SIGNAFUSE Bioactive Strip (SBS); SIGNAFUSE PuttyMQV · Traditional 12/05/2023SE
K193513SIGNAFUSE Bioactive Bone GraftMQV · Traditional 06/18/2020SE
K162860MCS Bone GraftMQV · Traditional 02/13/2017SE

Questions and answers

When was StimTrial Neuromodulation System cleared by the FDA?

StimTrial Neuromodulation System (K243782) received a 510(k) decision of Substantially Equivalent on July 16, 2025, 219 days after the submission was received.

What is the product code of K243782?

The FDA product code is GZF – Stimulator, Peripheral Nerve, Implanted (Pain Relief), a Class II (moderate risk) device regulated under 21 CFR 882.5870.